lobbying_activities: 2271225
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2271225 | 9ae8aefa-327e-4ad9-8a44-ab60c6ccbf56 | Q1 | FAEGRE BAKER DANIELS CONSULTING | 34158 | NATIONAL ASSOCIATION OF BOARDS OF PHARMACY | 2019 | first_quarter | PHA | Pharmacy regulation; Prescription drug monitoring | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE | 110000 | 0 | 0 | 2019-04-18T09:37:38.423000-04:00 |